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Missed Opportunities to Prescribe HIV
Pre-Exposure Prophylaxis by Primary Care
Providers in Saint Louis, Missouri
Rupa R. Patel, MD, MPH,1 Philip A. Chan, MD, MS,2 Laura C. Harrison,1 Kenneth H. Mayer, MD,3–5
Amy Nunn, ScD, MS,6,7 Leandro A. Mena, MD, MPH,8 and William G. Powderly, MD1
Abstract
Purpose: Optimal HIV pre-exposure prophylaxis (PrEP) scale-up in the United States requires prescribing by
primary care providers (PCPs). We assessed barriers to patients obtaining PrEP from their PCPs.
Methods: Patients seeking PrEP at an Infectious Diseases (ID) Clinic in St. Louis, Missouri from 2014 to 2016
were asked about demographics, sexual behaviors, whether PrEP was initially sought from their PCP, and bar-
riers to obtaining PrEP from their PCP. Multivariable logistic regression was performed to identify predictors for
having asked a PCP for PrEP.
Results: Among 102 patients, the median age was 29 years, 58% were white, and 88% were men who have sex
with men. Most (65%) had a PCP and, of these, 48% had asked their PCP for PrEP, but were not prescribed it.
About half (52%) reported that their PCPs perceived prescribing PrEP as specialty care. Many (39%) indicated
that they felt uncomfortable discussing their sexual behaviors with their PCP. Patients with an HIV-positive sex
partner in the last 3 months were less likely to ask for PrEP from their PCPs than others (Adjusted Odds Ratio:
0.07; 95% CI: 0.01–0.53). Eighty-three percent of patients were referred to a new PCP with whom they could feel
more comfortable discussing PrEP.
Conclusions: During initial PrEP implementation, ID specialists can play an important role in providing education
and linking PrEP patients to PCPs. However, PCPs may need additional training about PrEP and how to provide
culturally sensitive sexual healthcare, if widespread scale-up is to be effective in decreasing HIV incidence.
Keywords: healthcare providers, HIV prevention, implementation, pre-exposure prophylaxis (PrEP), primary care
Introduction
In 2014, over 40,000 human immunodeficiency virus(HIV) infections were diagnosed in the United States.1
Antiretroviral pre-exposure prophylaxis (PrEP) is an HIV
prevention approach that has the potential to reduce the num-
ber of new HIV infections significantly. Currently available,
FDA-approved PrEP is a fixed dose combination of emtrici-
tabine and tenofovir disoproxil fumarate (FTC/TDF), which
is taken once daily by at-risk HIV-negative individuals to
prevent HIV acquisition. Major studies have demonstrated
the efficacy of PrEP in preventing HIV among men who
have sex with men (MSM), heterosexuals, and injection
drug users.2–6 The Centers for Disease Control and Preven-
tion (CDC) estimates that national PrEP implementation
could potentially reduce HIV incidence by 70% by 2020.7
Expanding PrEP use alone among key populations has the
potential to prevent an estimated 50,000 new infections.8
The CDC and the International Antiviral Society-USA
Panel recommend integrating PrEP into routine HIV preven-
tion services offered by primary care providers (PCPs).9,10
As PrEP is implemented in nonresearch settings, non-
infectious diseases (ID) specialists will play a critical role
in scale-up. The number of ID specialists is declining.11–13
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Moreover, encouraging PCPs to prescribe PrEP will integrate
sexual health services with primary care, which is more holistic
for otherwise healthy patients.14 However, few (7%) PCPs
have prescribed PrEP despite moderate levels of awareness
of (66%) and high willingness to prescribe PrEP (91%).15 Rea-
sons for a lack of provider prescribing include a lack of aware-
ness, comfort with prescribing antiretrovirals, and organization
administrative support, as well as concerns regarding risk com-
pensation.16–28 The goals of this study were to explore whether
patients seeking PrEP at an ID specialty clinic were engaged in
primary care, if they had asked their PCPs about PrEP before
seeking specialty care, and to identify the reasons why patients
did not ask their PCPs for PrEP and why PCPs had declined to
prescribe PrEP.
Methods
We conducted a cross-sectional survey among new patients
who presented for PrEP care at the Washington University in
St. Louis (WUSTL) ID specialty clinic between June 2014 and
February 2016. Referrals to the clinic were from friends, word
of mouth, community providers, community-based organiza-
tions, and self-referral. The self-administered survey, per-
formed during the first appointment at the WUSTL ID
specialty clinic, included questions about demographics, sex-
ual behaviors, and whether patients had a PCP for PrEP. Sur-
vey answers were verified by the ID physician. A PCP was
defined as a ‘‘primary care provider’’ whom they visited
within the 12 months before visiting the WUSTL ID clinic.
Patients with a PCP were asked why they did not seek or ob-
tain PrEP services from their PCP. We reviewed medical re-
cords to see if patients, who were referred to a PCP, had
obtained a PCP within 12 months of the patient’s initial clinic
visit date. We obtained the reasons for not obtaining a new
PCP after referral from clinic charts and patient verification.
Study inclusion criteria were 18 years or older, presented at
the WUSTL ID specialty clinic for care, and were able to pro-
vide written informed consent. The study was approved by the
WUSTL Institutional Review Board.
We also reviewed available results of sexually transmitted
infections (STI) testing, which was performed during routine
PrEP care in accordance with the CDC PrEP Clinical Prac-
tice Guidelines.10 STIs tested for were syphilis with rapid
plasma reagin (RPR) and Neisseria gonorrhea (NG) and
Chlamydia trachomatis (CT) with nucleic acid amplification
testing at any one site, including pharyngeal, urine, or rectal
(Gen-Probe TIGRIS APTIMA Combo 2 Assay, Hologic,
Inc., San Diego, CA for NG/CT and Alere Inc., Waltham,
MA for RPR). RPR tests were confirmed with fluorescent
treponemal antibody absorption testing (ZEUS Scientific,
Branchburg, NJ).
Data were analyzed by multivariable logistic regression to
determine the association of demographic and behavioral
variables with patients who: (1) Had a PCP; and (2) Asked
their PCP for PrEP; and (3) Felt uncomfortable discussing
sexual behaviors with their PCP. Demographic variables
were age, gender, race, education, annual income, and insur-
ance. Behavioral variables were total sexual partners and had
anal or vaginal sex with a known HIV-positive partner in the
last 3 months, MSM, laboratory-confirmed STI test on initial
visit, MSM who had condomless anal sex in the past 3 months,
having ever used intravenous drugs, and self-reported history
of mental illness (e.g., anxiety, depression, schizophrenia,
attention-deficit/hyperactivity disorder, or bipolar disorder).
MSM was defined as a male patient who reported a history
of having sex with men on the self-administered survey.
The association between independent variables and the out-
comes was initially assessed using chi-square and Fisher’s
exact tests. Statistical tests were two-sided and the signifi-
cance level was set at 0.05. Multivariable logistic regression
was performed for all outcomes. Variables included in the re-
gression analysis included those that were significant in
Table 1. Patient Characteristics (N = 102)
n %
Demographics
Median age (years) (IQR) 29 (25–34)
Age (years)
18–24 23 22.5
25–34 55 53.9
>34 24 23.5
Gender
Male 93 91.1
Female 8 7.8
Other 1 1.0
Race
White 59 57.8
Black 32 31.4
Latino/Hispanic 3 2.9
Asian 3 2.9
Multiracial 5 4.9
Highest level of education
Less than college 35 34.7
College graduate 36 35.6
Postgraduate 30 29.7
Annual income ($)
£12,000 24 24.2
12,001–24,000 20 20.2
24,001–36,000 22 22.2
>36,000 33 33.3
Has insurance coverage
None 5 4.9
Publica 8 7.8
Private 88 86.3
Other 1 1.0
Sexual risk
Median sexual partners in the
last 3 months (IQR)
2 (1–5)
Men who have sex with men (MSM) 90 88.2
Having an HIV-positive sex partner
in the last 3 months
43 42.2
Laboratory-confirmed STI
on initial visitb
14 14.0
MSM who had condomless anal sex
in the past 3 months (n = 90)
63 70.0
Has ever used intravenous drugs 2 2.0
Self-reported history of mental illness 33 32.4
Certain numbers may not sum to the total sample due to missing data.
aPublic insurance includes Medicaid, Medicare, and a city insur-
ance program called Gateway to Better Health.
bLaboratory-confirmed STI includes any one positive test result
for syphilis, Neisseria gonorrhea (pharyngeal, urine, or rectal), or
Chlamydia trachomatis (pharyngeal, urine, or rectal).
IQR, interquartile range; STI, sexually transmitted infection.
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bivariate analysis and also the demographic variables of age,
race, education, and annual income. In addition, we adjusted
for gender for the outcome of having had a PCP. For each in-
dependent variable, an odds ratio (OR), 95% confidence in-
terval (95% CI), and P value were calculated. Analysis
was performed in SPSS Statistics for Windows Version 23
(IBM Corporation, Armonk, NY).
Reasons for not being prescribed or not asking for PrEP
were obtained by using open-ended survey questions. These
answers were categorized by two independent study team
members and the frequencies for each category were reported.
Reasons for not obtaining a new PCP after referral were cat-
egorized and the frequencies reported. Each patient could
have multiple reasons for each question.
Results
A total of 108 new patients presented at the WUSTL ID spe-
cialty clinic for PrEP care during the study period; 102 were en-
rolled in the study and six declined to participate in the study.
Among the 102 patients, the median age was 29 years (Inter-
quartile Range [IQR] 25–34); 91% were male, 58% white,
31% Black, 3% Latino/Hispanic, 65% graduated college, me-
dian annual income was $27,000 (IQR $13,350–$46,000), and
95% had any insurance coverage. Most (88%) patients were
MSM, 42% had an HIV-positive sex partner in the last 3
months, 14% had a laboratory-confirmed STI, and 2% had
ever used intravenous drugs. Among MSM, 70% reported con-
domless anal sex in the past 3 months. Notably, 32% of the pa-
tients self-reported a history of mental illness (Table 1).
Thirty-five percent (36/102) of patients did not have a PCP
when they sought PrEP at the clinic (Fig. 1). Compared with
those with a PCP, those without a PCP were more often non-
white: 69% (25/36) versus 27% (18/66, P< 0.001). Of those
who had a PCP, 48% reported asking their PCP for PrEP, but
were not prescribed it (Fig. 1). Age, race, education, and self-
reported history of mental illness were significantly associated
with having had a PCP in bivariate analysis. Multivariable re-
gression analysis for having a PCP is demonstrated in Table 2.
When adjusting for age, gender, education, annual income,
and self-reported history of mental illness, race remained a
significant predictor for having a PCP; non-whites were less
likely to have a PCP than whites (OR: 0.32; 95% CI: 0.10–
0.96, P= 0.04).
Compared with those who asked for PrEP from their PCP,
those who did not more often had an HIV-positive sex
partner (65%, 22/34 vs. 21%, 6/28; P< 0.001) and felt un-
comfortable discussing their sexual behaviors with their
PCP (55%, 18/33 vs. 23%, 7/31; P= 0.01). Age, race, annual
income, self-reported history of mental illness, and having
had an HIV-positive sex partner were significantly associated
with having asked a PCP for PrEP in bivariate analysis.
Table 3 displays the multivariable regression analysis results
for patients having asked their PCP for PrEP when adjusting
for age, race, education, annual income, self-reported history
of mental illness, and having an HIV-positive sex partner.
Self-reported history of mental illness (OR: 18.19; 95% CI:
FIG. 1 Forty-eight percent (32/
66) of PrEP seekers with a PCP
were not prescribed PrEP and po-
tentially missed the opportunity to
obtain PrEP within a primary care
setting before presenting to an ac-
ademic infectious diseases clinic.
PCP, primary care provider; PrEP,
pre-exposure prophylaxis.
Table 2. Multivariable Regression Analysis
for Having a Primary Care Provider Among
102 Patients Who Sought HIV Pre-Exposure
Prophylaxis Care at an Academic Infectious
Diseases Clinic, June 2014–February 2016
Variable OR 95% CI aORa 95% CI
Age (years)
18–24 1.0 1.0
25–34 2.07 0.77–5.56 1.05 0.27–4.05
>34 4.15* 1.15–14.92 1.42 0.25–8.02
Gender
Male 1.0 1.0
Female 1.73 0.33–9.05 6.99 0.95–51.16
Race
White 1.0 1.0
Non-white 0.17*** 0.07–0.43 0.32* 0.10–0.96
Education
Less than college 1.0 1.0
College graduate 4.00** 1.46–10.97 3.12 0.88–11.15
Postgraduate 4.38** 1.49–12.89 2.44 0.59–10.07
Annual income ($)
£12,000 1.0 1.0
12,001–24,000 0.69 0.21–2.28 0.77 0.18–3.24
24,001–36,000 2.26 0.66–7.76 1.90 0.40–8.99
>36,000 3.14 0.99–10.01 1.72 0.36–8.30
Self-reported history
of mental illness
No 1.0 1.0
Yes 3.46* 1.27–9.45 2.78 0.78–9.93
aAdjusted for age, gender, race, education, annual income, and
self-reported history of mental illness.
*P£ 0.05.
**P£ 0.01.
***P £ 0.001.
OR, odds ratio; aOR, adjusted odds ratio; 95% CI, 95% confi-
dence interval.
252 PATEL ET AL.
D
ow
nl
oa
de
d 
by
 W
as
hi
ng
to
n 
U
ni
v 
fro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
6/
20
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
2.73–121.39, P = 0.003) was a significant positive predictor
of having asked their PCP for PrEP; however, having an
HIV-positive sex partner in the last 3 months (OR: 0.07;
95% CI: 0.01–0.53, P= 0.01) was a significant negative pre-
dictor for having asked for PrEP.
Overall, 39% of those who reported having a PCP indi-
cated that they had felt uncomfortable speaking to their
PCP about their sexual behavior. However, of those who
felt comfortable, 62% asked their PCP for PrEP, but were
not provided with a prescription (Fig. 2). Having had an
HIV-positive sex partner was significantly associated with
patients having felt uncomfortable discussing their sexual
behavior with their PCP in bivariate analysis. Table 4 dis-
plays the multivariable regression analysis results for pa-
tients who felt uncomfortable discussing their sexual
behaviors with their PCP. When adjusting for age, race, ed-
ucation, and annual income, patients who had an HIV-
positive sex partner in the last 3 months were more likely
to have felt uncomfortable discussing their sexual behavior
with their PCP (OR: 5.46; 95% CI: 1.37–21.77, P = 0.02).
Of the 32 patients who asked their PCP for PrEP and were
not prescribed it, 29 reported reasons; some reasons were (1)
the PCP’s perception that prescribing PrEP is not a primary
care activity (52%), (2) the PCP was unaware of PrEP (21%),
and (3) the PCP did not feel comfortable prescribing PrEP
(10%). Furthermore, of the 34 patients who did not ask
their PCP for PrEP, 32 patients shared their reasons, which
included: (1) PrEP was initiated by an ID specialist (i.e., at
an inpatient or outpatient visit) for patients who were not seek-
ing PrEP, but rather were offered PrEP, and they followed up
at the WUSTL ID specialty clinic (i.e., without engaging the
PCP) (31%), (2) they were uncomfortable discussing their
sexual behaviors with their PCP (22%), (3) they were uncom-
fortable revealing that they had an HIV-positive sex partner to
their PCP (19%), and (4) the perception that PrEP should be
obtained from an ID or HIV specialist (16%).
As a part of PrEP services at the ID clinic, those who had
indications for PrEP but did not have a PCP (n= 36), were un-
comfortable with their PCP (n= 25), or who were comfortable
with but not prescribed PrEP by their PCP (n= 24) were re-
ferred to a new PCP. Overall, ID doctors referred 83% (85/
102) of PrEP seekers who sought care at the clinic to another
Table 3. Multivariable Regression Analysis for
Patients Having Asked a Primary Care Provider
for HIV Pre-Exposure Prophylaxis Before Seeking
Care at an Academic Infectious Diseases Clinic,
June 2014–February 2016 (N = 66)
Variable OR 95% CI aORa 95% CI
Age (years)
18–24 1.0 1.0
25–34 0.47 0.11–2.06 2.30 0.21–25.75
>34 0.10** 0.02–0.56 0.46 0.03–6.70
Race
White 1.0 1.0
Non-white 0.30* 0.09–0.97 0.25 0.04–1.55
Education
Less than college 1.0 1.0
College graduate 1.88 0.52–6.76 1.46 0.18–11.92
Postgraduate 1.38 0.37–5.14 1.18 0.11–13.02
Annual income ($)
£12,000 1.0 1.0
12,001–24,000 0.56 0.10–3.25 1.03 0.03–31.96
24,001–36,000 0.74 0.16–3.50 1.00 0.08–13.53
>36,000 0.20* 0.05–0.84 0.05 0.002–1.10
Self-reported history of mental illness
No 1.0 1.0
Yes 8.91*** 2.84–27.98 18.19** 2.73–121.39
Having an HIV-positive sex partner in the last 3 months
No 1.0 1.0
Yes 0.13*** 0.04–0.39 0.07** 0.01–0.53
aAdjusted for age, race, education, annual income, self-reported
history of mental illness, and having an HIV-positive sex partner.
*P£ 0.05.
**P£ 0.01.
***P£ 0.001.
FIG. 2. Number of primary
care referrals made as part of
routine PrEP care at an aca-
demic infectious diseases
clinic.
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PCP (Fig. 2). Patients were referred to a PCP who was able to
assess sexual risk in a culturally sensitive manner and who
was PrEP aware; this referral network had been developed
by the clinic. Thirty-two percent of the total referred patients
obtained a PCP within 12 months of their initial clinic date
(Fig. 2); of those without a PCP on intake, 36% (13/36)
obtained a PCP. There were 19 total PCPs located at 14 differ-
ent healthcare centers: three providers at three federally qual-
ified health centers (FQHC), one provider at a university
student health clinic, nine providers at seven private practices,
and six providers at three health systems-based clinics.
Of the 27 patients who obtained a PCP, 15% (4/27) se-
lected a FQHC provider, 7% (2/27) a student health clinic
provider, and 78% (21/27) a private or health systems-
based PCP. Patients (n = 58) who did not obtain a PCP
reported the following reasons: (1) they did not follow-up
with the referral because they forgot, did not have time, or
wanted to get a PCP ‘‘later’’ (36%), (2) moved out of state
or discontinued PrEP before the 12-month time period of
analysis (28%), (3) felt comfortable with their established
PCP, did not want a new one, and wanted to receive PrEP
from a specialist (24%), (4) did not have options to obtain
a new PCP due to their insurance coverage (10%), and (5) be-
came infected with HIV (2%).
Discussion
We documented that individuals seeking PrEP faced nu-
merous barriers to obtaining PrEP from PCPs in metropolitan
Saint Louis, Missouri. Major barriers included not having a
PCP, having a PCP who was unaware of and/or perceived
PrEP to be a specialist’s responsibility, not knowing a PCP
could prescribe PrEP, and having a PCP but not feeling com-
fortable discussing sexual behaviors. Forty-eight percent of
these at-risk patients asked for PrEP from their PCPs, but
were not prescribed it, creating a large missed PrEP-
prescribing opportunity by PCPs. In the United States, wide-
spread implementation of PrEP requires PCPs to be aware of
and willing to prescribe PrEP.
The study findings are consistent with previous studies and
suggest several potential approaches to improve PrEP deliv-
ery by PCPs.14,16,18–28 These include improved education
and training about sexual behaviors and PrEP, as well as in-
terventions to address bias and stigma related to sexual be-
haviors.29 This study supports findings by Oldenburg et al.,
which revealed that structural stigma at the state level
leads to decreased use of PrEP for HIV prevention.30 Olden-
burg et al. demonstrated that Missouri had a less supportive
social environment based on state-level structural stigma.30
We corroborate this study with our finding that 39% of indi-
viduals did not feel comfortable discussing their sexual be-
haviors with their PCPs, highlighting the importance of
combating this stigma on an individual provider–patient
level. The importance of eliciting sexual histories in cultur-
ally competent ways is increasingly recognized, and tools
are available to enhance primary provider cultural compe-
tence. Knowledge on how to initiate sexual behavior discus-
sions will allow for adequate risk assessments and provide an
avenue to prescribe PrEP if indicated.31 Resources exist to
assist providers in developing comfortable settings for pa-
tients who identify as sexual or gender minorities or who
have HIV-positive sex partners.
As noted in other PrEP studies, we observed the ‘‘purview
paradox,’’ a term referring to the contradictory belief among
HIV specialists and PCPs about whose domain it is to be the
main PrEP prescriber.18 Many PCPs report perceiving that
PrEP was not a part of their expertise, and preferred to
refer PrEP patients to ID specialists.18 We observed that pa-
tients reported this reason when they asked for PrEP from
their PCPs, but also reported believing that PrEP was not
under the PCP’s prescribing jurisdiction. These challenges
might be best addressed by local provider training programs
and community awareness events about PrEP provision.
Our study also highlights the importance of access to care
and having a PCP. A third of patients who sought PrEP care
at our clinic had not engaged with a PCP in the last 12 months.
This study’s findings are consistent with national data showing
that 47% of Americans of all ages reported not visiting a PCP
in 2012.8 Referrals for PCPs within this study resulted in 32%
of patients obtaining a PCP with whom they could feel more
comfortable.
This study reports on the potential of a PrEP referral to be
the gateway for comprehensive primary and preventive care.
In this capacity, PrEP is an opportunity to link otherwise
healthy people to other services, including vaccinations
and mental health. In this study, ID and HIV specialists be-
came the gateway to PrEP while also being the gateway to
primary care homes for a proportion of PrEP seekers. ID phy-
sicians and specialty clinics have the ability to play an impor-
tant role in providing PrEP services, while also training PCPs
and garnering support from healthcare organization adminis-
trative leaders to establish a network of PrEP-prescribing
PCPs during initial local implementation as we had. We saw
Table 4. Multivariable Regression Analysis
for Patients Who Felt Uncomfortable Discussing
Their Sexual Behaviors with Their Primary Care
Provider Before Seeking HIV Pre-Exposure
Prophylaxis Care at an Academic Infectious Diseases
Clinic, June 2014–February 2016 (N = 64)
Variable OR 95% CI aORa 95% CI
Age (years)
18–24 1.0 1.0
25–34 0.73 0.17–3.06 1.10 0.15–8.02
>34 2.41 0.52–11.10 6.25 0.59–65.98
Race
White 1.0 1.0
Non-white 0.99 0.32–3.03 0.59 0.13–2.62
Education
Less than college 1.0 1.0
College graduate 0.58 0.15–2.26 0.77 0.14–4.18
Postgraduate 1.64 0.44–6.11 6.12 0.79–47.11
Annual income ($)
£12,000 1.0 1.0
12,001–24,000 0.51 0.09–3.11 0.16 0.01–2.01
24,001–36,000 0.57 0.13–2.57 0.47 0.07–3.30
>36,000 0.45 0.12–1.76 0.05* 0.01–0.55
Having an HIV-positive sex partner in the last 3 months
No 1.0 1.0
Yes 2.86* 1.01–8.12 5.46* 1.37–21.77
aAdjusted for age, race, education, annual income, and having an
HIV-positive sex partner.
*P £ 0.05.
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an increase in several new PrEP-providing locations (three
FQHCs, a student health center, and several private sector
clinic locations) that were not previously providing PrEP,
as a result of our efforts to create a PCP referral network
for our patients.
Further studies are needed to evaluate how to successfully
link individuals prescribed PrEP to primary care services,
and to assess if these individuals are comfortable receiving
PrEP from their PCPs. Over 60% of patients who were referred
to a PCP did not follow through within 12 months. Understand-
ing the gaps in the specialist-to-PCP PrEP care transition or the
desire not to have a PCP will help better incorporate PrEP into
broader preventive care on a population level.
Limitations
Limitations to this study include a small sample size, pa-
tient self-reported reasons for not being prescribed PrEP,
and study conduction at a single academic institution,
which lessens generalizability. Although we did not catego-
rize denial of prescription by the provider based on individ-
ual risk, we reported many characteristics regarding this
patient sample that demonstrated substantial risk for HIV
acquisition.
Conclusion
PrEP has the potential to curb HIV incidence in the United
States and PrEP implementation will need to be adapted for
each geographic and cultural context. PrEP holds the power
to engage individuals in comprehensive preventive health-
care who were not in routine care previously. However,
these early adopting PrEP users will need to have a comfort-
able environment in which to disclose their sexual behaviors
and to have supportive interactions with the healthcare sys-
tem. Addressing these factors will help to establish the foun-
dation for successful PrEP care retention in the region. Until
primary care organizations develop a large cadre of clinically
competent and culturally sensitive PrEP providers, ID spe-
cialists will need to assist in initial PrEP care provision
and to develop networks where PrEP seekers can transition
their care to the hands of PCPs, thereby fostering a sustain-
able PrEP implementation platform.
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